Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].

Pandit, Anuja; Bhalani, Nirav; Bhushan, B L Shashi; Koradia, Parshottam; Gargiya, Shweta; Bhomia, Vinay; Kansagra, Kevinkumar

Pandit, Anuja; Bhalani, Nirav; Bhushan, B L Shashi; Koradia, Parshottam; Gargiya, Shweta; Bhomia, Vinay; Kansagra, Kevinkumar.

Pandit A; National Cancer Institute, Badsa, Jhajjar, Haryana 124105, India.
Bhalani N; Rhythm Heart Institute, Near Siddharth Bungalows, Sama Savli Road, Vadodara 390022, Gujarat, India.
Bhushan BLS; Victoria Hospital, Bangalore Medical College & Research Institute, Fort K R Road, Bangalore Urban, Karnataka 560002, India.
Koradia P; BAPS Pramukh Swami Hospital, Shri Pramukh Swami Maharaj Marg, Adajan Char Road, Adajan, Surat 395009, Gujarat, India.
Gargiya S; Tapan Research Centre, Basement Tapan Hospital Nr. Platinum Hall, Anandnagar Cross Road Satellite, Ahmedabad 380015, Gujarat, India.
Bhomia V; Sanjivani Super Speciality Hospital, 1, Uday Park Society, Nr. Sunrise Park, Vastrapur, Ahmedabad 380015, Gujarat, India.
Kansagra K; Zydus Research Centre, Clinical R & D, Cadila Healthcare Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad 382213, Gujarat, India. Electronic address: kevinkumarkansagra@zyduscadila.com.

Int J Infect Dis ; 109: 322, 2021 Aug.

Article in English | MEDLINE | ID: covidwho-1415440

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Randomized controlled trials Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: J.ijid.2021.06.030

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google